{
  "id": 15798835,
  "title": "Indaptus Therapeutics completes $24 million private placement of common stock",
  "url": "https://urgent.news/2026/10/20/indaptus-therapeutics-completes-24-million-private-placement-of",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-10-20T20:57:53.000Z",
  "source": {
    "name": "Investing.com",
    "slug": "investing-com",
    "url": "https://www.investing.com/news/sec-filings/indaptus-therapeutics-completes-24-million-private-placement-of-common-stock-93CH-4961153"
  },
  "original_language": "en",
  "account": null,
  "summary": "Indaptus Therapeutics, Inc., a Delaware-based company with its headquarters in New York, recently completed a private placement of its common stock, raising approximately $24 million in gross proceeds. The company announced the successful completion of the transaction on October 16, 2026, following an initial agreement signed on September 8, 2026. Indaptus issued a total of 20,338,974 shares, each with a par value of $0.01, to participating investors. The stock price of INDP jumped 14% over the past week, reaching $2.96 per share, but an analysis from InvestingPro indicates that the shares are currently overvalued relative to its Fair Value estimate.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}